About this episode
This episode explores SS-31, also known as Elamipretide, a unique mitochondria-targeting peptide with the potential to protect cellular energy, fight oxidative stress, and slow aspects of aging. Over forty-five minutes, we dive into how SS-31 works, the science behind its ability to stabilize cardiolipin in mitochondria, and what current research says about its role in energy, muscle performance, heart health, eye protection, and neurodegenerative conditions. You’ll also hear about its limitations, ongoing clinical trials, and where this breakthrough peptide might fit into the future of health and longevity.
Get every episode summarized
Each time The Peptide Effect publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Peptide Effect
The Hidden GLP-1 Switch: How These Drugs May Reprogram Pancreatic Cells
The Peptide Effect
The Science of Peptide-Based Myostatin Inhibitors: Can We Unlock More Muscle?
The Peptide Effect
Apolipoprotein-Targeting Peptides: The Future of Cholesterol, Brain Health, and...
The Peptide Effect
Border Seizures and the Peptide Market: What’s Happening to Supply, Pricing, and...
The Peptide Effect